greeksoup/ stock research
Stock research / United States / AZN / Year to 31 December 2023

AstraZeneca PLC (AZN) annual results, year to 31 December 2023: revenue USD 45,811 million, from the 20-F

AstraZeneca PLC files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2023 it reported revenue of USD 45,811 million, up 3.3% on the year before. Its profit attributable to shareholders was USD 5,955 million, up 81.1%, and diluted earnings per share USD 3.81.

Revenue
USD 45,811 million
+3.3% on the year
FY2016FY2023
Operating margin
17.9%
8.5% a year earlier
FY2016FY2023
Net income
USD 5,955 million
+81.1% on the year
FY2016FY2023
Diluted EPS
USD 3.81
+80.6% on the year
FY2016FY2023

this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2022Dec 2023
Revenue44,35145,811
Cost of sales12,3918,268
Gross profit31,96037,543
Research and development9,76210,935
Selling, general and administrative18,41919,216
Operating profit3,7578,193
Finance costs1,3461,626
Profit before tax2,5016,899
Income tax-792938
Profit for the year3,2935,961
Profit attributable to shareholders3,2885,955
Filing20-F20-F
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2022Dec 2023
Diluted EPS2.113.81
Basic EPS2.123.84
Filing20-F20-F

USD per ordinary share, as filed.

Cash flow

Year toDec 2022Dec 2023
Cash from operations9,80810,345
Purchase of property, plant and equipment1,0911,361
Free cash flow8,7178,984
Cash from investing-2,960-4,064
Cash from financing-6,823-6,567
Dividends paid4,3644,481
Filing20-F20-F

USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2022Dec 2023
Funded by
Equity attributable to shareholders37,03739,143
Non-controlling interests21.023.0
Borrowings, as filed28,27927,494
Lease liabilities9531,128
Other liabilities30,19333,331
Total equity and liabilities96,483101,119
Owned
Property, plant and equipment8,5079,402
Goodwill19,82020,048
Other intangible assets39,30738,089
Cash and cash equivalents6,1665,840
Trade and other receivables10,52112,126
Inventories4,6995,424
Other assets7,46310,190
Total assets96,483101,119
Filing20-F20-F

USD million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2022Dec 2023
Gross margin72.1%82.0%
Operating margin8.5%17.9%
Net margin7.4%13.0%
Free cash flow margin19.7%19.6%
Return on year-end equity8.9%15.2%
Effective tax rate-31.7%13.6%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2023, filed 24 February 2026: the filing. The figures are in US dollars as filed.